β Subunit heterogeneity of L-type Ca2+ channels in smooth muscle tissues  by Reimer, Daniel et al.
L Subunit heterogeneity of L-type Ca2 channels in smooth muscle
tissues
Daniel Reimera, Irene G. Hubera, Maria L. Garciab, Hannelore Haasec, Jo«rg Striessniga;*
aInstitut fu«r Biochemische Pharmakologie, Peter-Mayrstrasse 1, A-6020 Innsbruck, Austria
bMerck Research Laboratories, Rahway, NJ, USA
cMax-Delbru«ck Centrum fu«r Molekulare Medizin, Berlin, Germany
Received 19 November 1999
Edited by Jacques Hanoune
Abstract Various L subunit isoforms stabilize different gating
properties of voltage-gated L-type Ca2+ channels. We therefore
investigated the expression of Ca2+ channel L subunit isoforms in
different smooth muscle types on the protein level by immuno-
blotting and immunoprecipitation employing L subunit-selective
sequence-directed antibodies. From the four known L subunit
isoforms only L2 and L3 were detected in porcine uterus, bovine
trachea and bovine aorta membranes. Multiple immunoreactive
L2 bands were detected in a tissue-selective manner indicating
structural heterogeneity of L2. Immunoprecipitation of (+)-
[3H]isradipine-prelabeled channels revealed that L2 and L3
participate in Ca2+ channel formation in uterus and trachea,
and L3 in aortic smooth muscle. We conclude that L2 and L3
subunits form L-type Ca2+ channels in smooth muscle tissues.
This subunit heterogeneity may be important to fine-tune channel
function.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Voltage-gated Ca2 channels mediate depolarization-in-
duced Ca2 in£ux into electrically excitable cells and thereby
control important physiological processes, such as muscle
contraction, neuronal plasticity, neurotransmitter and hor-
mone secretion, and gene transcription. At least six di¡erent
types of Ca2 channels (high voltage-activated L-, P-, Q-, R-
and N-type channels; low voltage-activated T-type channels)
can be discriminated based on pharmacological and biophys-
ical criteria [1]. Di¡erent K1 subunit isoforms (K1A to I and
K1S) comprise the pore-forming region of the various channel
types [1]. K1 subunits of high voltage-activated channels form
hetero-oligomeric complexes with accessory K2-N, L and Q sub-
units, which modulate channel function and expression [2].
Whereas all channel types are found in neurons, muscle cells
only express L- and T-type Ca2 channels.
Ca2 channel function is ¢ne-tuned by di¡erent mechanisms
including phosphorylation/dephosphorylation [3], G-protein
modulation [4,5] and subunit composition [6,7]. The physio-
logical importance of channel ¢ne-tuning by accessory sub-
units is evident from recently described genetic disorders lead-
ing to dysfunction of Ca2 channels in neurons. Disruption of
one of the four L subunit genes (L4) in the lethargic mouse
mutant results in seizures and ataxia [8]. A similar phenotype
is found in stargazer mutant mice characterized by a defect
neuronal Q subunit (‘stargazin’, [9]). These examples illustrate
that even minor changes in channel expression and/or gating
cause alterations in depolarization-dependent Ca2 in£ux in-
compatible with normal neuronal function. Consequently, our
understanding of physiological channel function in neuronal
and non-neuronal tissues requires the detailed biochemical
analysis of their subunit composition.
Considerable plasticity of Ca2 channel function is caused
by the existence of four distinct L subunit isoforms (L1^L4),
which di¡erentially a¡ect the voltage-dependent gating of the
pore-forming K1 subunit [6,10^13]. Recent biochemical studies
have shown that all four isoforms can associate to various
extents with P/Q-, N- or L-type channels in mammalian brain
[14^16], whereas only L2 subunits were found to form L-type
channels in heart muscle [16]. In contrast, such information is
lacking for smooth muscle L-type Ca2 channels, whose func-
tional ¢ne-tuning is important to maintain normal muscular
tone in tissues such as blood vessels, airway and uterus
smooth muscle.
In the present study we therefore determined the L subunit
expression in aorta, trachea and uterus smooth muscle on the
protein level as well as their association with L-type Ca2
channels.
2. Materials and methods
2.1. Materials
Reagents were obtained from the following sources: (+)-
[3H]isradipine, ( þ )-[3H]isradipine from New England Nuclear (Vien-
na, Austria); protease inhibitors, bovine serum albumin (essentially
fatty acid free), protein A-Sepharose, lectin from triticum vulgaris,
and CHAPS from Sigma (Vienna, Austria); digitonin from Fluka
Biochemica (Basel, Switzerland); prestained molecular weight markers
from Biorad; glutathione-Sepharose from Pharmacia (Vienna, Aus-
tria).
2.2. Membrane preparation
Rabbit cerebral cortex membranes were prepared as described [16].
Porcine heart and uterus were rapidly excised in a local slaughter
house and immediately placed in ice-cold homogenization bu¡er
(20 mM NaHCO3, containing a protease inhibitor mix consisting of
0.2 mM PMSF, 0.5 mM benzamidine, 2 mM iodacetamide, 1 WM
pepstatin A, 1 Wg/ml leupeptin, 1 Wg/ml aprotinin). The tissues were
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then homogenized by a polytron (2U20 s) and by 10^15 strokes in a
Dounce homogenizer. Microsomes were collected by centrifugation at
45 000Ug (10 min; 4‡C) and washed three times with bu¡er A (50 mM
Tris^HCl, pH 7.4, containing the above protease inhibitor mix).
Membranes were resuspended in the same bu¡er at a membrane pro-
tein concentration of about 5 mg/ml and stored at 380‡C until use.
Bovine trachea and aorta sarcolemmal membrane vesicles were pre-
pared as described previously [17].
2.3. A⁄nity puri¢cation of L subunits
Glutathione-S-transferase (GST) and a GST-fusion protein (GST-
AIDA) of the K1 subunit interaction domain of the K1A subunit
(AIDA) were prepared as described previously [16]. All further steps
were carried out on ice or at 4‡C. 10^20 mg microsomal protein
isolated from rabbit brain, porcine heart or smooth muscle tissues
were solubilized in 9 ml of bu¡er A containing 1 M NaCl and 1%
(w/v) CHAPS. 10 Wg AIDA-GST or GST were coupled to 30 Wl
aliquots of glutathione-Sepharose equilibrated in bu¡er B (bu¡er A
containing 0.1 M NaCl and 0.1% (w/v) CHAPS) and washed three
times with the same bu¡er. Solubilized membranes were diluted
10-fold in bu¡er A and 4 ml were mixed with the coupled gluta-
thione-Sepharose beads overnight. The beads were washed three times
with 1.5 ml of bu¡er B, mixed with SDS^polyacrylamide gel electro-
phoresis sample bu¡er (3 min, 95‡C) and the eluted proteins separated
on 8% or 10% SDS^polyacrylamide gels.
Western blotting was carried out according to standard procedures
[16].
2.4. Sequence-directed antibodies
Sequence-directed antibodies (raised as described previously in rab-
bits [16]) against the following peptide epitopes were employed (amino
acid positions are given according to the sequences in [18]): L1b, 516^
530; L2, 595^604; L3, 470^483; L4, 460^474. Anti-Lcom was raised
against residues 61^79 in L1a [19], and anti-K1C against K1C residues
818^835 [20].
2.5. Partial puri¢cation and immunoprecipitation of prelabeled Ca2+
channels
Typically 10^20 mg of membrane protein was prelabeled with 1^2
nM (+)-[3H]isradipine for 60 min at 25‡C in bu¡er A containing
0.1 mM CaCl2. Prelabeled membranes were solubilized in 1% (w/v)
of digitonin and puri¢ed by wheat germ agglutinin (WGA) a⁄nity
chromatography [16]. Puri¢ed fractions were immediately used in im-
munoprecipitation experiments or stored at 380‡C. Protein concen-
trations were determined according to Bradford [21] using bovine
serum albumin as a standard.
For immunoprecipitation of prelabeled Ca2 channels saturating
concentrations of a⁄nity-puri¢ed antibodies were coupled to protein
A-Sepharose. The antibody-protein A-Sepharose complex was then
washed three times with ice-cold RIA bu¡er (20 mM Tris^HCl, pH
7.4, 150 mM NaCl, 0.5 mg/ml bovine serum albumin, 0.1% (w/v)
digitonin) and incubated with 0.05^0.25 ml (3000^4000 dpm) of
WGA-puri¢ed prelabeled Ca2 channels. After four 1.5 ml washes
in RIA bu¡er bound radioactivity was determined by liquid scintilla-
tion counting. Channel-associated (+)-[3H]isradipine was determined
by ¢ltration over GF/C Whatman ¢lters as described [16].
2.6. Radioligand binding studies
Modulation of (+)-[3H]isradipine binding to cardiac and uterus
microsomal membranes by unlabeled Ca2 antagonists and divalent
cations was performed as described [22] employing 0.2^0.3 mg/ml of
membrane protein and 0.2 nM of radioligand. Incubation was for
45 min at 37‡C. Non-speci¢c binding was measured in the presence
of 1 WM ( þ )-isradipine. The concentration of bound radioactivity was
determined by rapid ¢ltration over GF/C Whatman ¢lters, pretreated
for 45 min with 0.1% (v/v) polyethylenimine.
2.7. Statistics
Data are given as means þ S.E.M. for the indicated number of ex-
periments. Binding parameters were calculated by computer ¢tting the
data to the general dose-response equation [23].
Fig. 1. Expression of L subunits in cerebral cortex, heart microsomes and di¡erent smooth muscle tissues. The results of Western blot analysis
are shown. L subunits were puri¢ed from membrane proteins isolated from cerebral cortex (CTX), heart (HT) and di¡erent types of smooth
muscle (UT, AO, TR) by GST-AIDA a⁄nity chromatography, separated by SDS^polyacrylamide gel electrophoresis together with prestained
molecular weight markers and subjected to immunoblot analysis with L subunit isoform-selective antibodies. For all tissues the same amounts
of membrane protein were used for solubilization and subsequent a⁄nity puri¢cation (4 ml of diluted extracts, 35^58 Wg of protein). The mi-
gration of speci¢c immunoreactivity as discussed in the text is indicated by arrows for L1b (A), L2 (B), L3 (C), L4 (A) and Lcom (D). The spe-
ci¢city of the a⁄nity puri¢cation step is shown in panels B and D where either GST-AIDA (GA) or GST alone (G) was used for a⁄nity puri-
¢cation. The migration of prestained marker proteins (112 in panel A; 112, 78 and 49 kDa in panels B^D) is indicated on the left. The
apparent molecular masses of L1b and the L4 doublet were 79 and 59/62 kDa, respectively. One of at least four independent experiments yield-
ing similar results is shown.
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3. Results
3.1. L Subunit expression in smooth muscle
As no systematic analysis of L subunit isoform expression
has been reported on the protein level we investigated the
expression of L subunits in Western blots employing sub-
unit-selective sequence-directed antibodies in smooth muscle
from bovine aorta (AO), trachea (TR) and porcine uterus
(UT) membranes. To achieve maximal sensitivity and specif-
icity L subunits were enriched from CHAPS extracts of bovine
AO, bovine TR and porcine UT by a⁄nity puri¢cation of L
subunits on GST-AIDA-Sepharose beads as described in Sec-
tion 2. Cerebral cortex and heart extracts were used as con-
trols. Fig. 1 illustrates that, in accordance to previous work
[16], all four L subunits were speci¢cally enriched from cere-
bral cortex extracts. In all three types of smooth muscle only
L2 and L3 isoforms were detected (Figs. 1B, C and 2), whereas
L1b and L4 immunoreactivity were below the detection limit
(Fig. 1A). Several bands ranging from apparent molecular
masses of 65 to 107 kDa were speci¢cally enriched and stained
with our L2-speci¢c antibody in a tissue-speci¢c manner (see
below). The density of L2 immunoreactivity in UT and TR
was similar to cortex and heart, but was clearly lower in AO
(only faint bands visible Figs. 1B and 2).
L3 subunits, migrating as 63 þ 1 (n = 3) kDa bands, were less
abundant in all three types of smooth muscle as compared to
cerebral cortex and again lowest in AO (Fig. 2B). In porcine
heart membranes a very faint band of L3 immunoreactivity
was detectable only in two out of eight experiments employing
three di¡erent membrane preparations. This suggests that L3
subunits are expressed at signi¢cantly higher levels in TR, UT
and even AO than in heart muscle.
To determine the relative abundance of L2 vs. L3 subunits,
Western blots were stained with a generic L subunit antibody
directed against an epitope conserved in all L subunit isoforms
(anti-Lcom). In cerebral cortex anti-Lcom stained a heteroge-
neous 79 kDa band (which has recently been shown to com-
prise comigrating L1b and L2 immunoreactivities [16]) as well
as a 63/59 kDa doublet (corresponding to L3 and L4 immu-
noreactivity [16]). In contrast, only bands corresponding to L2
immunoreactivity were stained by anti-Lcom in heart, UT,
and TR (arrows in Fig. 1D). Weak L2 staining was also
present in AO (not shown). No bands corresponding to L3
immunoreactivity (Fig. 1C) could be demonstrated in these
tissues due to the limited reactivity of this antibody. L2
must therefore represent the major L subunit isoform.
3.2. L2 subunit heterogeneity
In contrast to L3 (Fig. 1C), L2 immunoreactivity was asso-
ciated with multiple bands. In heart muscle the majority of
immunostaining was associated with a 65 þ 1 kDa (n = 4)
band, whereas two larger bands (89 þ 1 and 74 þ 2 kDa,
n = 3) were less abundant (Figs. 1B and 2). The 89 and 74
kDa bands were detected as the major forms in cerebral cor-
tex, TR and AO (Figs. 1 and 2). In contrast, in UT a di¡use
89^107 kDa band was most abundant. This staining pattern
was tissue speci¢c and reproducibly obtained in at least ¢ve
independent puri¢cation experiments.
3.3. L subunit association with L-type Ca2+ channels
To investigate if L2, L3 subunits or both are associated with
L-type Ca2 channels in smooth muscle tissues, solubilized L-
type channel complexes speci¢cally prelabeled with (+)-
[3H]isradipine were partially puri¢ed by wheat germ lectin
a⁄nity chromatography and subjected to immunoprecipita-
tion with saturable concentrations of Lcom and isoform-selec-
tive antibodies. High a⁄nity (+)-[3H]isradipine binding has
previously been shown to be associated with L-type Ca2
channels in cerebral cortex, heart, TR and AO [24,25]. (+)-
[3H]isradipine binding to porcine UT membranes was also
stereospeci¢c and modulated by di¡erent classes of Ca2 an-
tagonists (stimulation by (+)-cis-diltiazem, partial inhibition
by (+)-verapamil) (Fig. 3) similar to heart muscle (see legend
to Fig. 3). In heart and uterus binding was stimulated by Ca2
(maximal stimulation at 1 mM, n = 3). These properties dem-
onstrate that speci¢c (+)-[3H]isradipine binding also occurs to
L-type Ca2 channels in porcine uterus. Saturating concentra-
tions of anti-K1C immunoprecipitated 71 þ 5% of prelabeled
Ca2 channels in UT (n = 3), 57 þ 3% in TR (n = 3) and
63 þ 11% in AO (n = 3). Therefore the majority of L-type
channels in these tissues contain K1C as a pore-forming sub-
unit. Immunoprecipitation with anti-Lcom revealed that most
L-type Ca2 channel complexes are also associated with L
Fig. 2. L2 Heterogeneity in cerebral cortex, heart and smooth
muscle tissues. Western blot analysis of L subunits a⁄nity puri¢ed
from cerebral cortex (CTX), heart (HT), uterus (UT), trachea (TR),
and aorta (AO) membranes was carried out as in Fig. 1 with anti-
L2 antibodies. Molecular weight markers are as in Fig. 1. Separa-
tion was on an 8% SDS^polyacrylamide gel. The arrows indicate
the molecular masses (in kDa) of the individual L2 subunit bands.
Fig. 3. Modulation of (+)-[3H]isradipine binding to porcine uterus
membranes: binding of (+)-[3H]isradipine (0.2 nM) to uterus mem-
branes (0.16^0.18 mg/ml of protein) was determined in the absence
and presence of di¡erent unlabeled Ca2 antagonists or Ca2. One
representative experiment is shown. The following binding parame-
ters (IC50 or EC50, slope, binding inhibition/stimulation to % of
control) were calculated from at least three independent experi-
ments: (+)-isradipine (b): 0.3 þ 0.4 nM, 0.8 þ 0.1, 100%; (3)-isradi-
pine (a) : 53 þ 1 nM, 0.9 þ 0.1, 100%; (+)-verapamil (F) : 8.6 þ 6.3
WM, 0.4 þ 0.1, 52 þ 2%; (3)-verapamil (E) : no inhibition up to
100 WM; (+)-cis-diltiazem (R) : 0.91 þ 0.15 nM, 1.1 þ 0.1, 135 þ 6%.
As a comparison the binding parameters obtained for cardiac
muscle Ca2 channels are also given (nv3): (+)-isradipine: 0.4 þ 0.8
nM, 1 þ 0.1, 100%; (3)-isradipine: 63 þ 1 nM, 0.8 þ 0.1, 100%; (+)-
verapamil: 1.7 þ 0.3 WM, 0.6 þ 0.3, 32 þ 3%; (3)-verapamil: no in-
hibition up to 100 WM; (+)-cis-diltiazem (R) : 7.3 þ 1.4 WM,
0.5 þ 0.1, 156 þ 5%.
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subunits in smooth muscle tissues (Fig. 4). In UT the majority
of channel complexes (80 þ 2%, n = 5) was associated with L2
and to a smaller extent with L3 (20 þ 2%, n = 4; Fig. 4). Anti-
L2 and -L3 antibodies also immunoprecipitated (+)-
[3H]isradipine binding activity (13 þ 1, n = 6, and 7 þ 1%,
n = 5, respectively; Fig. 4) from solubilized TR membranes
but together only accounted for about 20% of the total L
immunoreactivity associated with L-type channels in this tis-
sue (Fig. 4). In solubilized AO membranes a small fraction of
channels was recognized by anti-L3 (8 þ 1%, n = 5), whereas no
clear association with L2 (2 þ 1%, n = 6) could be demon-
strated. In all cases immunoprecipitation was speci¢c because
it was not observed with equivalent concentrations of control
rabbit immunoglobulins (see legend to Fig. 4).
4. Discussion
Our study provides the ¢rst analysis of the L subunit com-
position of L-type Ca2 channels in di¡erent types of smooth
muscle. Only signi¢cant expression of L2 and L3 subunits
occurs in the smooth muscle tissues investigated whereas
L1b and L4 polypeptides could not be detected. In UT, HT
and TR L2 and L3 participate in the formation of L-type Ca2
channel complexes. No evidence was obtained for association
with L2 in AO, although it cannot be ruled out by our data.
Detection of L3 subunit expression in both Western blot anal-
ysis and immunoprecipitation experiments clearly argues
against the conclusions from a recent study in which no L3
subunit protein could be detected in aortic smooth muscle
[26].
We have recently also described L subunit heterogeneity of
L-type Ca2 channels in mammalian brain [16] where associ-
ation with all isoforms could be demonstrated. L subunit iso-
forms di¡erentially a¡ect L-type Ca2 channel function. This
has been shown by their coexpression with L-type K1C sub-
units in heterologous systems. For example, in contrast to L3,
L2 subunits slow voltage-dependent inactivation [11^13] and
do not support prepulse facilitation [11,27]. Therefore subunit
composition could play an important role to ¢ne-tune channel
function in mammalian brain as well as smooth muscle. In
smooth muscle tissues L-type Ca2 channel activity partici-
pates in the regulation of basal muscular tone by regulating
steady-state intracellular free Ca2 concentrations at resting
membrane potentials. At these potentials macroscopic Ca2
inward currents are absent but a constant Ca2 channel-medi-
ated Ca2 in£ux occurs through non-inactivating channels
(‘window currents’) [28^30]. Di¡erent extents of non-inactivat-
ing current components stabilized by L2 and L3 are therefore
expected to a¡ect steady-state intracellular free Ca2 concen-
trations and thus muscular tone. Therefore the ratio of chan-
nels associated with L2 or L3 subunits may play an important
role to ¢ne-tune contractile smooth muscle activity and there-
by a¡ect physiological processes such as uterus contraction,
airway and vascular resistance. Whether changes of the L
subunit composition of L-type Ca2 channels occurs under
certain physiological (e.g. during pregnancy) or pathophysio-
logical (e.g. hypertension or asthma) conditions and serves as
a modulatory mechanism of voltage-gated Ca2 in£ux must
be determined in further studies. Evidence for changes in Ca2
channel expression have already been obtained on the level of
K1 subunits. For example, K1C expression and L-type Ca2
current are upregulated in spontaneously hypertensive rats
(SHR) [31] and changes in the relative expression of K1C
splice variants are observed during pregnancy [32].
In UT the L-type Ca2 channel activity immunoprecipi-
tated by the L2- and L3-selective antibodies quantitatively
accounted for all channel-bound L subunits as determined
by immunoprecipitation with anti-Lcom. Therefore we could
quantify the L2/L3 ratio in this tissue. In contrast, only about
20% of the L subunit-associated channels were recognized by
these isoform-selective antibodies in TR and AO. We reported
a similar observation in mammalian brain, where isoform-se-
lective antibodies together accounted for all L subunit-associ-
ated L-type channels solubilized from cerebral cortex but not
from cerebellum (66%) and hippocampus (70%) [16]. This
¢nding can be explained by di¡erent extents of C-terminal
proteolysis of L subunits, which would remove the C-terminal
epitopes of the isoform-selective antibodies but not the N-
terminal epitope of anti-Lcom. This proteolytic activity would
have to occur despite the presence of protease inhibitors in
our bu¡ers and its extent must vary considerably between
tissues. Alternatively, one or more so far not identi¢ed L
subunit isoforms could exist, which could escape immunopre-
cipitation by isoform-selective antibodies but may contain the
highly conserved epitope recognized by anti-Lcom.
Another unexpected observation was the heterogeneity
found for the L2 subunit immunoreactivity in immunoblots.
The 42 kDa di¡erence in molecular mass between the smallest
(65 kDa, most abundant in cardiac muscle) and the largest
band (80^107 kDa, most abundant in UT) cannot be ex-
plained by proteolysis because both bands are speci¢cally rec-
ognized by anti-L2 as well as anti-Lcom and must therefore
contain the respective epitopes. C-terminal proteolysis can be
ruled out because it would remove the anti-L2 epitope. Pro-
Fig. 4. Speci¢c immunoprecipitation of solubilized (+)-
[3H]isradipine-labeled L-type Ca2 channels from porcine heart and
di¡erent smooth muscle tissues. Ca2 channel complexes were la-
beled with 0.2 nM (+)-[3H]isradipine, solubilized in 1% (w/v) digito-
nin and partially puri¢ed by a⁄nity chromatography on WGA-Se-
pharose. Immunoprecipitation experiments were performed as
described in Section 2. The radioactivity immunoprecipitated by sat-
urating concentrations of anti-Lcom or the isoform-selective anti-
bodies were normalized with respect to the total channel-associated
radioactivity employed in the assay (s 1900 dpm HT, s 2200 dpm
UT, s 2000 dpm TR, s 1900 dpm AO). Numbers denote the L iso-
form to which antibodies were generated; com, anti-Lcom. Immuno-
precipitation by equal concentrations of non-immune rabbit immu-
noglobulins was less than 10% of channel-associated radioactivity,
and was subtracted from the radioactivity immunoprecipitated by L
subunit antibodies to yield speci¢c immunoprecipitation.
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teolysis could only remove the portion N-terminal to the anti-
Lcom epitope. However, complete removal of this region
would only account for a di¡erence in molecular mass of 2^
3 kDa (molecular mass of peptide from N-terminus to start of
antibody epitope). Although we cannot rule out that proteol-
ysis contributes to the observed L subunit heterogeneity to
some extent, we propose that other factors such as post-trans-
lational modi¢cation or the existence of yet unknown splice
variants must explain our ¢ndings.
Our ¢nding should prompt further studies in e.g. L3 sub-
unit-de¢cient mice which should reveal the physiological sig-
ni¢cance of L subunit heterogeneity predicted from our bio-
chemical analysis.
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